$
0. 66
+0.01
+1.0736%
$
1M Market Cap
- P/E Ratio
- Div Yield
18,891 Volume
-9.72 Eps
$ 0.65
Previous Close Investors:
Want to track RKDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcadia Biosciences Inc. (RKDA) Statistics
Valuation metrics
Market Cap 1M
Enterprise value 122.78K
Trailing P/E (ttm) -0.1
Forward P/E -0.84
PEG ratio -0
Price/Sales (ttm) 0.23
Price/Book (mrq) 0.33
Enterprise Value/Revenue 0.03
Enterprise Value/EBITDA -0.01
Overview
Shares outstanding 1.37M
Float 2.05M
Shares short 6.34K
% Held by insiders 0.01%
% Held by institutions 0.02%
Average volume (10 days) 11.34K
Average volume (90 days) 2.36M
Price summary
52-Week low 0.59
52-Week high 6.71
Beta 0.52
50-Day moving average 0.67
200-Day moving average 1.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 1 Mar 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.96%
Operating margin -2.01%
Operational effectiveness
Return on assets -1.75%
Return on equity -2.19%
Income Statement
Revenue (ttm) 4.86M
Revenue per share (ttm) 3.48
Quarterly revenue growth (yoy) -0.26%
Gross profit (ttm) 1.75M
EBITDA -5.22M
Net income to common (ttm) -2.34M
Diluted EPS (ttm) -6.81
Quarterly earnings growth (yoy) -0.26%
Balance Sheet
Total cash (mrq) 4.56M
Total cash per share (mrq) 2.72
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.79%
Book value per share (mrq) 2.11
Cash Flow
Cash flow statement -4.74M
Levered free cash flow (LFCF) 721.75K
